A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study. [electronic resource]
Producer: 20070816Description: 1037-45 p. digitalISSN:- 0340-6245
- Animals
- Bleeding Time
- Blood Coagulation -- drug effects
- Carotid Artery Thrombosis -- blood
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Electric Stimulation
- Fibrin -- metabolism
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- chemically induced
- Hirudins -- adverse effects
- Ligation
- Male
- Metalloendopeptidases -- adverse effects
- Partial Thromboplastin Time
- Rats
- Rats, Wistar
- Recombinant Fusion Proteins -- adverse effects
- Thrombin Time
- Time Factors
- Tissue Plasminogen Activator -- pharmacology
- Vascular Patency -- drug effects
- Venae Cavae -- surgery
- Venous Thrombosis -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.